App for Pregnancy Smoking Cessation With Peer Support

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorMichigan State University

About this trial

The objectives of this project are to develop, implement, and test the feasibility and effectiveness of an artificial intelligence adaptive mobile pregnancy tobacco cessation app-based intervention using deep tailoring and a self-nominated support person, and to build mHealth research capacity in Romania. The central hypothesis is that the intervention will show evidence of feasibility and effectiveness in increasing positive support, pregnancy cessation, and postnatal abstinence. The intervention is grounded in Self-Determination Theory (SDT) and Motivational Interviewing (MI), a counselling style that is effective in assisting people to quit smoking. The app will be novel in its use of the unique functionality of smartphones, use of reinforcement learning (RL) and deep tailoring to continuously adapt the intervention, the emphasis on increasing positive support, and the use of the app by both smoker and support person. The long-term goal of the research program is to use mHealth for smoking cessation leveraging the unique functionality of smartphones and to continue building mHealth research capacity and developing research networks in Central and Eastern Europe (CEE) and other LMICs.

Aim 1 (R21 phase). Develop and test the feasibility and acceptability of the SFT2.0 app-based mobile smoking cessation intervention with a support person during pregnancy and postpartum in Romania. Through a user-centered and iterative design the investigators will enhance the SFT1.0 app, deepen the tailoring, incorporate RL, expand the app for use by any support person, and test the intervention including the app and MI video counseling in a series of usability studies and a 12-week open trial (n=20).

Aim 2 (R33 phase). Test the SFT2.0 app-based smoking cessation intervention in a hybrid effectiveness and implementation randomized controlled trial. The investigators will randomize 375 pregnant smokers and their support persons to i) a fixed arm, including the SFT2.0 app for both, and fixed pre- and postnatal MI counseling; ii) an RL-adaptive arm, with the app continuously optimizing as-needed MI counseling; or iii) control group.

Aim 3 (R21 and R33 phases). Develop mHealth research capacity by enhancing individual and institutional research capabilities in Romania and expanding the existing international research network.

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

age>=18

pregnant

user of regular cigarettes

availability of Android phone with broadband data

Disqualifiers

None

Trial design

Design model

Parallel

Treatments tested in this trial

  • SFT 2.0

    Behavioral

    The SFT 2.0 intervention will include the use of the SFT 2.0 smoking cessation app, Motivational Interviewing (MI) counseling, and the support of a peer person

  • Active control

    Behavioral

    Low dose prenatal and postnatal MI video counseling, defined as one prenatal session and one postnatal session

Treatment groups

790 Participants
are divided into 3 treatment groups
Group A: App+fixed MIExperimental treatment 1 intervention
Group B: Adaptive app + as-needed MIExperimental treatment 1 intervention
Group C: ControlActive comparator 1 intervention

Trial outcomes

Primary outcomes

1

Change in smoking cessation

7-day point biochemically verified prevalence of tobacco use

Time frame
3 and 6 months after birth
2

Change in postpartum abstinence

Fewer than 5 cigarettes smoked since birth

Time frame
3 and 6 months after birth
3

Reach

Proportion and representativeness (e.g., age, ethnicity) of dyads who enroll in each trial arm compared to each other and the general population of pregnant women in Romania

Time frame
1 month after birth
4

Adoption

Proportion of participants who enroll in SFT2.0 by recruitment strategy

Time frame
1 month after birth

Secondary outcomes

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Michigan State University

Lead sponsor

Babes-Bolyai University

Collaborator

Wake Forest University Health Sciences

Collaborator

University of Michigan

Collaborator